The GLP-1 patch was the logical next step in that marketing evolution: take the same ingredients already being sold in capsules, put them in a transdermal patch (a format associated in consumers' minds with legitimate nicotine and hormone therapies), and market them with GLP-1 keywords
Patients receive an individualized prescription, not a form-based dispensing
Dermatol Ther 33, e13312.CrossRefGoogle ScholarPubMed Sercombe, L, Veerati, T, Moheimani, F, et al
If youre trying to get Aetna to cover Ozempic for prediabetes, it will most likely be denied
"Mydayis- dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate capsule, extended release"
Unverified Supply Chains Risk: Because AOD-9604 isnt widely approved, products from unverified sources may lack purity or potency